The estimated Net Worth of Jose E Almeida is at least $14.4 Million dollars as of 23 May 2016. Mr. Almeida owns over 11,691 units of Baxter International stock worth over $459,106 and over the last 11 years he sold BAX stock worth over $0. In addition, he makes $13,913,800 as Chairman of the Board, President, and Chief Executive Officer at Baxter International.
Jose has made over 2 trades of the Baxter International stock since 2015, according to the Form 4 filled with the SEC. Most recently he bought 11,691 units of BAX stock worth $499,790 on 23 May 2016.
The largest trade he's ever made was buying 11,691 units of Baxter International stock on 23 May 2016 worth over $499,790. On average, Jose trades about 351 units every 13 days since 2014. As of 23 May 2016 he still owns at least 11,691 units of Baxter International stock.
You can see the complete history of Mr. Almeida stock trades at the bottom of the page.
Jose E. Almeida is the Chairman of the Board, President and Chief Executive Officer of the Company. He began serving as an executive officer of the company in October 2015. He served as Senior Advisor with The Carlyle Group from May 2015 until October 2015. Previously, he served as the Chairman, President and Chief Executive Officer of Covidien plc (Covidien) from March 2012 to January 2015, prior to Medtronic plc’s (Medtronic) acquisition of Covidien, and President and Chief Executive Officer of Covidien from July 2011 to March 2012. Mr. Almeida served in other executive roles with Covidien (formerly Tyco Healthcare (Tyco)) between April 2004 and June 2011. Mr. Almeida is a member of the Board of Directors of Walgreens Boots Alliance, Inc.
As the Chairman of the Board, President, and Chief Executive Officer of Baxter International, the total compensation of Jose Almeida at Baxter International is $13,913,800. There are no executives at Baxter International getting paid more.
Jose Almeida is 57, he's been the Chairman of the Board, President, and Chief Executive Officer of Baxter International since 2016. There are 14 older and 13 younger executives at Baxter International. The oldest executive at Baxter International Inc. is James Gavin, 74, who is the Independent Director.
Jose's mailing address filed with the SEC is 100 NORTH TRYON STREET, , CHARLOTTE, NC, 28255.
Over the last 22 years, insiders at Baxter International have traded over $966,809,165 worth of Baxter International stock and bought 178,227 units worth $6,261,495 . The most active insiders traders include Point Llc Loeb Daniel S Third, Michael F Mahoney, and Jeffrey A Craig. On average, Baxter International executives and independent directors trade stock every 37 days with the average trade being worth of $3,609,738. The most recent stock trade was executed by Jeanne K Mason on 1 March 2024, trading 64,488 units of BAX stock currently worth $2,397,019.
baxter provides a broad portfolio of essential renal and hospital products, including home, acute and in-center dialysis; sterile iv solutions; infusion systems and devices; parenteral nutrition; biosurgery products and anesthetics; and pharmacy automation, software and services. the company’s global footprint and the critical nature of its products and services play a key role in expanding access to healthcare in emerging and developed countries. baxter’s employees worldwide are building upon the company’s rich heritage of medical breakthroughs to advance the next generation of healthcare innovations that enable patient care.
Baxter International executives and other stock owners filed with the SEC include: